Mesenchymal Stem Cells and Cell-Free Preparations for Treating Atopic Dermatitis

    January 2022 in “ Biocell
    Trinidad Montero‐Vílchez, Manuel Sánchez‐Díaz, CAROLINA MONTERO-VILCHEZ, Álvaro Sierra-Sánchez, Salvador Arias‐Santiago
    Image of study
    TLDR Mesenchymal stem cells and their secretions might help treat chronic skin inflammation in atopic dermatitis.
    Atopic dermatitis (AD) is a chronic skin inflammatory disease that can be difficult to treat in some patients. The paper discusses the potential of using Mesenchymal stem cells (MSCs) and cell-free preparations like MSCs-Conditioned Medium (CM) and MSCs-exosomes as treatments for AD. MSCs are non-hematopoietic multipotent adult progenitor cells with the ability to modulate the immune response and self-regenerate to repair tissue damage. MSCs-CM and MSCs-exosomes contain molecules secreted by stem cells that could also be beneficial for treating AD. The paper reviews the current development of these potential treatments.
    Discuss this study in the Community →

    Cited in this study

    1 / 1 results